ArticleJournal of hematopathology2025

Prognostic outcomes of diffuse large B-cell lymphoma patients with myelocytomatosis oncogene (MYC) and B-cell lymphoma 2 (BCL2) co-expression.

Supanut Kumjan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.